 1
Fusion IP plc Annual Report and Accounts 2011
Business and portfolio highlights:
•	 Revenue & portfolio return increased by 35% to £5.9m (2010: £4.4m)
•	 Profit, excluding subsidiary spin-out costs and amortisation, increased by 68%  
to £4.2m (2010: £2.5m)
•	 Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) increased  
by 650% to £3.0m (2010: £0.4m)
•	 Profit before taxation of £1.0m (2010: £1.6m loss)
•	 Cash balances of £2.0m (2010: £4.6m)
•	 Co-investment agreement with IP Group implemented on three occasions
•	 One new portfolio company started and funded in the year (Perlemax)
•	 Six portfolio companies in trading phase of growth, three of which are trading profitably
•	 Portfolio company Simcyp increased turnover by 25% to £5.9m (2010: £4.7m) and  
profit by 35% to £2.3m (2010: £1.7m)
•	 Portfolio company Magnomatics increased turnover by 62% to £1.3m (2010: £0.8m) 
•	 £1.6m invested in the portfolio companies by Fusion (2010: £1.8m) 
•	 £6.1m invested in the portfolio companies by third party investors (2010: £6.9m)
•	 15 funding rounds completed by portfolio companies (2010: 20)
Post year end highlights:
•	 Diurnal, our Cardiff-based drug development company, completed a £335k funding 
round in August that will enable its lead product, Chronocort
®
, to complete the profile 
stage of its Phase I clinical trials
•	 Mesuro, our Cardiff-based Radio Frequency (RF) technology company, raised a further 
£440k in August to support its growing sales activity
Recognition:
Following on from last year’s awards for Magnomatics and Simcyp, our portfolio companies 
continue to be recognised for their achievements: 
•	 In December 2010 MedaPhor, our Cardiff based ultrasound simulation company, won 
the MediWales Industry Innovation Award for its new ScanTrainer ultrasound simulator 
that is revolutionising how medical trainees acquire the necessary obstetrics and 
gynaecology skills needed to safely examine patients; and
•	 In October 2011 Simcyp won Insider’s ‘Growth 100 Rising Star Award’ for the UK’s  
most promising business.
Highlights
